BRIEF-Nyrada Receives Written FDA Feedback For Xolatryp Cardioprotection Program

1

Oct 13 (Reuters) – Nyrada Inc: * RECEIVES WRITTEN FDA FEEDBACK ON PRE-IND FOR XOLATRYP CARDIOPROTECTION PROGRAM Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)